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Introduction
Although the majority of secondary esophageal cancers
are caused by direct invasion of tumors from nearby
organs, metastatic esophageal carcinomas from distant
primary malignancies, especially the lung, are relatively
rare, and the optimal treatment remains unclear.1 Here,
we report a case of metastatic esophageal carcinoma
with initial presentation of dysphagia. Although pul-
monary origin was highly suspected by immunohisto-
chemical staining, no definite lung lesion was detected
by imaging studies, bronchoscopy and surgical explo-
ration. To the best of our knowledge, metastatic esoph-
ageal carcinoma from occult lung cancer (AJCC TNM
stage TX) is a very rare occurrence.
Case Report
A 66-year-old man was admitted to our hospital for
progressive dysphagia and weight loss for 1 month.
Physical examination and medical history were unre-
markable. Esophagography showed eccentric narrow-
ing of the middle third of the esophagus, with a smooth
mucosal surface (Figure 1A). On esophagoscopy, 
external compression, with apparently normal overlying
mucosa at 30 cm from the incisors, was noted. Biopsy
revealed inflammation without malignant cells. Com-
puted tomography (CT) (5-mm slice) demonstrated
thickening of the esophageal wall and a mass lesion 
at the middle third of the esophagus (Figure 1B). No
abnormal lesion was found in the bilateral lung fields.
Laboratory data were unremarkable except for elevated
carcinoembryonic antigen (CEA; 64.45 ng/mL) and
carbohydrate antigen (CA) 19-9 (40.51U/mL), which
raised the possibility of malignancy. Both bronchoscopy
and colonoscopy were performed to exclude broncho-
genic and colorectal neoplasms.
Right-side muscle-sparing thoracotomy was carried
out under the suspicion of esophageal cancer. One large
mass lesion in the middle third of the esophagus was
found, which was tightly adhered to the azygos vein,
pericardium, aorta, bilateral main bronchus, and part
of the lung. Incision biopsy of the mass was performed,
and the frozen section showed poorly differentiated
carcinoma. Therefore, the operation proceeded with
subtotal esophagectomy, wedge resection of the 
adhered lung, reconstruction with a gastric tube via
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the retrosternal route, and cervical esophagogastric
anastomosis. Grossly, the esophageal tumor was firm,
yellow, and 6 ×5 ×5 cm in size (Figure 2). No definite
lesion was found in the nearby lung parenchyma.
Microscopic examination revealed adenocarcinoma
cells in the submucosal and muscular layers, with nor-
mal overlying mucosa (Figure 3A). Histological stains
(PAS-D and mucicarmine) and immunohistochemical
stains [pan cytokeratin AE1/AE3 and thyroid tran-
scription factor 1 (TTF-1)] were positive (Figure 3B).
Metastatic esophageal adenocarcinoma of pulmonary
origin, which might be disseminated through a lym-
phatic or hematogenous route, was highly suspected.
The tumor markers after resection showed marked
decline (CEA, 27.79 ng/mL; CA19-9, 29.59 U/mL).
The CEA level was 10.26ng/mL 2 weeks after surgery.
The patient’s recovery was uneventful, and oral intake
was well tolerated. He received adjuvant chemoradia-
tion (gemcitabine and cisplatin) because of mediasti-
nal lymph node involvement and possible residual
tumor infiltration from outward growth. After 1 year
of follow-up, there was no lung or endobronchial
lesion by imaging and bronchoscopy. The tumor mark-
ers had all returned to their normal ranges.
Discussion
Secondary esophageal cancer usually occurs by 3 mech-
anisms. The most common mechanism is the direct
extension of tumors from nearby organs.1,2 The other
2 mechanisms include metastasis via the lymphatic sys-
tem or the bloodstream from distant primary malig-
nancies, which are relatively rare.1,3 Mizobuchi et al
reviewed a total of 1,835 autopsy reports on patients
who had died of carcinoma. Metastases to the esoph-
agus were found in 112 patients; an incidence of 6.1%.3
However, less than one-third of these abnormalities
could be macroscopically detected.3 In another report
of autopsy data on 423 cases of primary lung cancer,
Antler and colleagues also found isolated esophageal
metastasis in 6.4% of bronchogenic carcinoma patients.4
Their study further showed that large-cell and small-
cell carcinomas have the highest predilection for gastro-
intestinal metastases.4
Symptomatic metastatic esophageal carcinoma is
extremely rare, and the presentation is usually progres-
sive dysphagia.1,2,4 Esophagography usually demon-
strates esophageal narrowing, with a smooth mucosal
surface, while CT usually depicts thickening of the
esophageal wall over the stenosis.1–3 The mechanisms
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Figure 1. (A) Esophagography showed eccentric narrowing of the middle third of the esophagus, with a smooth mucosal surface. (B)
Computed tomography of the chest demonstrated 1 mass lesion in the middle third of the esophagus, which occupied the subcarinal
space.
Figure 2. A specimen that consisted of en bloc-resected intra-
thoracic esophagus, including the tumor and lymph nodes. The
esophageal mucosa was grossly intact.
of lymphatic or bloodstream dissemination to the
esophagus result in the submucosal location of the
esophageal metastasis with normal overlying mucosa,
which makes diagnosis by endoscopic biopsy difficult,1
as in our case, in which the overlying mucosa was nor-
mal and accurate biopsy was not feasible. With the ad-
vent of positron emission tomography and endoscopic
ultrasound, the biopsy of submucosal lesions under
ultrasound guidance could potentially overcome the
diagnostic challenge and help establish definitive diag-
nosis before surgical exploration, thus providing bet-
ter options for some patients with inoperable tumors.1
Although many cancers, e.g. breast, kidney, gastro-
intestinal tract, lymphoid tissue, and prostate cancer,
have been shown to metastasize to the esophagus,
metastatic esophageal carcinoma from lung cancer
has rarely been reported, and the optimal treatment
remains unclear.1 Most patients with metastasis to the
esophagus are already in an advanced stage of disease.
Therefore, many authors have advocated sequential
dilation and/or stenting for local palliation, and che-
motherapy and/or radiotherapy for systemic control.1,3
The experience of surgical resection for metastatic
esophageal carcinoma of pulmonary origin is limited.
Inoshita et al reported the case of a 65-year-old man
who presented with progressive dysphagia.5 During
surgery for the esophageal lesion, squamous cell car-
cinoma of the lung in the right lower lobe was inci-
dentally discovered. The lung and esophageal lesions
were resected simultaneously. In a report by Oka et al,
a 54-year-old woman presented with dysphagia 5
years after left lower lobectomy and adjuvant chemo-
therapy for adenocarcinoma.2 Resection of the esoph-
agus was performed, and the histological patterns of
the esophageal tumor were similar to those of primary
lung cancer. In our case, the patient had no history of
malignant tumor. Preoperative workup, including chest
and abdominal CT, bronchoscopy and colonoscopy,
found no abnormal lesion other than the esophageal
mass. Manual palpation at exploratory thoracotomy
and surgical specimens also showed no definite lung
lesion. However, the results of immunohistochemical
staining supported adenocarcinoma (PAS-D and muci-
carmine positive) and epithelial origin (pan cytokeratin
AE1/AE3 positive). Although the positive TTF-1
staining indicated lung or thyroid origin, the normal
thyroid gland appearance on preoperative CT and ele-
vated CEA level made the possibility of thyroid origin
less likely. Furthermore, TTF-1 has sensitivity and speci-
ficity of 88% and 100%, respectively, in recognizing
lung adenocarcinoma for determining the primary
sites of metastatic cancer.6 In a study that used TTF-1
for identification of carcinoma origin, pulmonary origin
of metastases was confirmed in 27 of 37 cases with pos-
itive TTF-1 staining, whereas thyroid origin repre-
sented only a minority of cases.7 Wedge resection of
the adhered lung was performed in our patient, along
with esophagectomy. Thus, there was a possibility
that the primary tumor (such as bronchoalveolar car-
cinoma) might be in the specimen. In addition, the
characteristic submucosal infiltration of tumor cells 
in the esophagus raises the possibility of metastatic
lesions instead of direct invasion. Based on results of
clinical examination and pathological immunohisto-
chemical staining, metastatic esophageal carcinoma of
pulmonary origin was highly suspected. To the best of
our knowledge, this is the first reported case of meta-
static esophageal carcinoma from an occult TX stage
lung cancer. The patient received subtotal esophagec-
tomy with reconstruction and postoperative adjuvant
chemotherapy. So far, he has remained disease-free
and asymptomatic.
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Figure 3. (A) Histological examination showing adenocarcinoma cells in the submucosal layer, with normal overlying squamous epithe-
lium (original magnification, 100×). (B) Tumor cells (right half) were positive for thyroid transcription factor 1 staining. The nearby lung
parenchyma (left half) served as a positive internal control (original magnification, 200×).
In conclusion, we reported a case of metastatic
esophageal carcinoma. Based on the results of clinical
examination and immunohistochemical staining, pul-
monary origin was highly suspected. Our experience
suggested that, although chemotherapy is the rule of
thumb for systemic control, esophagectomy in selected
patients could provide excellent symptom palliation and
local control.
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